Venture • Education

Eight Roads Invests In div

On May 29, 2020, private equity firm Eight Roads invested in education company div

Investment Context
  • This is Eight Roads’ 5th transaction in the Education sector.
  • This is Eight Roads’ 23rd transaction in Japan.

Explore All 43 Venture Education Deals - Search the Database Free


Investment Summary

Date May 29, 2020
Target div
Sector Education
Investor(s) Eight Roads
Deal Type Venture

Target Company

div

Tokyo, Japan
div operates “Tech Camp”, a programming school, a short-term intensive training course designed to turn students into engineers. div was founded in 2012 and is based in Tokyo, Japan.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


Deal Context for Investor #
Overall 235 of 293
Sector: Education 5 of 8
Type: Venture 212 of 266
Country: Japan 23 of 25
Year: 2020 13 of 18
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-27 Otrium

Amsterdam, Netherlands

Otrium is a purpose-driven platform that envisions a world where all clothing that is produced is worn. With a technology-led approach, Otrium connects a growing global community with excess stock from leading brands. Otrium was founded in 2015 and is based in Amsterdam, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-11 Avidity Biosciences

San Diego, California, United States

Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies using its proprietary antibody oligonucleotide conjugate platform. Avidity Biosciences was founded in 2012 and is based in San Diego, California.

Sell -

Explore Related M&A Activity